Key Updates
Rigetti Computing (RGTI) has declined an additional 3.16% to $18.83 since the June 10th report, extending a persistent multi-week downtrend that has now accumulated to -14.99% YTD. The primary new development is the IQM Quantum Computers deployment at Oak Ridge National Laboratory — the first on-premises U.S. installation for a direct competitor — signaling intensifying competitive pressure in the federal and research quantum computing market. The investment thesis remains intact in terms of sector tailwinds, but near-term price action continues to deteriorate with no identifiable technical catalyst for reversal.
Current Trend
RGTI's price action remains firmly bearish across all measured timeframes. The stock is now down 14.99% YTD, 26.53% over the past month, and 14.99% over the past six months — all figures converging at the same level, indicating the bulk of the YTD damage was inflicted in the most recent month. The sequential decline from $21.77 (June 9th) → $19.45 (June 10th) → $18.83 (July 1st) reflects a controlled but persistent selling pattern with no meaningful recovery attempts. The stock is trading at its weakest level within the recent reporting window, suggesting the absence of a durable support floor at current prices.
Investment Thesis
The core investment thesis for RGTI rests on three pillars: (1) a substantial cash position of approximately $590 million providing operational runway, (2) Bernstein's identification of RGTI as one of the two most promising quantum computing pure-plays with implied market share significantly below analyst long-term expectations, and (3) a Mizuho price target of $33 — representing approximately 75% upside from current levels — anchored in the view that quantum computing will function as a specialized accelerator within a tri-processor architecture alongside CPUs and GPUs. The thesis is balanced against growing competitive dynamics, with IQM now entering the U.S. federal computing market and Quantinuum's $15.6 billion IPO establishing a new competitive benchmark in the sector.
Thesis Status
The growth thesis remains structurally supported by sector-level tailwinds — federal funding, analyst endorsements, and expanding commercial use cases — but is being progressively undermined by near-term competitive and sentiment headwinds. Quantinuum's flat IPO debut signals investor caution toward deep-tech valuations despite headline enthusiasm, a dynamic that directly weighs on RGTI's re-rating potential. IQM's U.S. market entry via Oak Ridge represents a concrete competitive incursion into the federal segment that RGTI targets. The thesis has not broken down, but the risk/reward balance has shifted modestly less favorable since the June 9th report, as the stock continues to underperform without a near-term catalyst to re-engage buyers.
Key Drivers
The following factors are currently shaping RGTI's price trajectory and investment outlook:
- IQM's U.S. Federal Market Entry: IQM deployed a 20-qubit Pathfinder system at Oak Ridge National Laboratory — the Department of Energy's flagship computing facility — marking its first on-premises U.S. installation. With 23 systems sold globally, IQM claims more on-premises deployments than any other manufacturer, directly challenging RGTI's positioning in the research and federal computing segments. (Business Wire, June 16)
- IQM European Expansion: IQM's deployment of a 54-qubit Radiance system at CINECA in Italy, integrated with the Leonardo supercomputer, further demonstrates the company's ability to execute at scale in high-performance computing environments — a competitive reference point for institutional procurement decisions. (Business Wire, June 11)
- Bernstein Sector Endorsement: Bernstein analysts identified RGTI as one of two top quantum computing stocks, citing current valuations as implying only 4% long-term market share — a low bar relative to the company's competitive positioning. Mizuho's $33 price target implies ~75% upside from current levels. (CNBC, June 8)
- Quantinuum IPO Sentiment Read-Through: Quantinuum priced its IPO at $60 (above the $53–$55 range), raised $1.68 billion at a $15.6 billion valuation, but closed essentially flat on its debut — indicating that institutional investors are applying valuation discipline to quantum hardware companies despite strong headline demand (20x oversubscription). This muted debut creates a cautious sentiment backdrop for RGTI. (PitchBook, June 5)
- Federal Funding Tailwind: The Trump administration's $2 billion quantum computing funding initiative — with Quantinuum designated to receive $100 million — confirms continued government support for the sector. While RGTI is not cited as a direct recipient in the available data, the broader federal commitment to quantum infrastructure supports the sector's long-term demand environment. (Bloomberg, June 4)
Technical Analysis
RGTI is trading at $18.83, establishing a new multi-week low within the current reporting cycle. The stock has failed to reclaim the $19.45 level from the June 10th report, which now acts as near-term resistance. The sequential decline pattern — $21.77 → $19.45 → $18.83 — reflects a series of lower highs and lower lows consistent with a sustained downtrend. The 1-month decline of 26.53% indicates the stock remains in a sharp corrective phase from what appears to have been a higher base in early June. No consolidation or base-building pattern is evident in the available price data. The 5-day decline of 3.58% and 1-day decline of 2.54% suggest continued selling pressure without capitulation-level volume signals. Key resistance is at $19.45 (prior report level) and $20.68 (June 6th level); near-term support is unconfirmed below current prices given the absence of a prior base at this level.
Bull Case
- Significant Analyst Upside and Low Implied Market Share: Bernstein identifies RGTI's current valuation as implying only 4% long-term quantum market share — a modest threshold for a leading superconducting quantum hardware company. Mizuho's $33 price target implies approximately 75% upside from current levels of $18.83, representing the strongest fundamental re-rating argument available. (CNBC, June 8)
- ~$590 Million Cash Position Provides Substantial Runway: RGTI's reported cash position of approximately $590 million insulates the company from near-term financing risk and enables continued R&D investment through the commercialization phase of quantum computing, reducing dilution and insolvency risk relative to earlier-stage peers. (CNBC, June 8)
- Structural Sector Tailwinds from Federal Investment: The Trump administration's $2 billion quantum computing funding program confirms sustained government demand for quantum hardware and services, creating a favorable procurement environment for established U.S.-based quantum hardware providers including RGTI. (Bloomberg, June 4)
- Tri-Processor Architecture as Long-Term Demand Driver: Bernstein's framework positions quantum computing not as a replacement for classical computing but as a specialized accelerator within a CPU/GPU/QPU architecture — a more defensible and near-term achievable commercial model that supports incremental revenue generation for superconducting hardware vendors like RGTI ahead of full fault-tolerance. (CNBC, June 8)
- Quantinuum IPO Validates Sector Institutional Interest: Despite a flat close, Quantinuum's IPO attracted 20x oversubscription and priced above its marketed range, confirming deep institutional appetite for quantum computing equity exposure. This validates the sector's investability and may channel incremental attention to RGTI as an established pure-play alternative. (Bloomberg, June 4)
Bear Case
- IQM's U.S. Federal Market Entry Intensifies Competition: IQM's deployment at Oak Ridge National Laboratory — a premier DOE facility — marks a direct competitive incursion into the federal and national laboratory segment that RGTI targets. With 23 on-premises systems globally and a claimed lead in deployed hardware, IQM represents a credible and accelerating competitive threat ahead of its own planned Nasdaq listing. (Business Wire, June 16)
- Quantinuum IPO Establishes Valuation Discipline Benchmark: Quantinuum's flat debut despite strong demand and above-range pricing signals that institutional investors are applying rigorous valuation scrutiny to quantum hardware companies. At a $15.6 billion valuation for a company with $30.9 million in 2025 revenue and a $192.6 million net loss, the market is clearly not extending unlimited premium multiples — a direct read-through risk for RGTI's own valuation. (PitchBook, June 5)
- Persistent and Accelerating Price Deterioration: RGTI has now declined 26.53% over the past month and 14.99% YTD, with each successive report establishing a new lower price point. The absence of any recovery attempt since the June 9th Bernstein-driven bounce ($21.77) indicates that positive analyst commentary is insufficient to reverse the prevailing selling pressure. (CNBC, June 8)
- Expanding Competitive Landscape with Multiple Well-Capitalized Entrants: Beyond IQM, the sector now includes Quantinuum ($1.68 billion raised, $15.6 billion valuation, Honeywell backing) and Infleqtion (Nvidia partnership) as increasingly well-resourced competitors. The broadening of the competitive set reduces RGTI's relative positioning advantage and may compress long-term market share assumptions. (Morningstar, June 5)
- Sector Sentiment Headwinds from Deep-Tech IPO Caution: PitchBook's characterization of Quantinuum's debut as a "fizzle" and the explicit contrast with Cerebras's 70% opening-day gain reflects broader investor caution toward deep-tech hardware companies relative to AI-adjacent names. This sentiment differential may continue to suppress RGTI's multiple expansion potential in the near term. (PitchBook, June 5)